Granisetron Hcl Tablets

— THERAPEUTIC CATEGORIES —
  • Nausea

Granisetron Hcl Tablets Generic Name & Formulations

General Description

Granisetron HCl 1mg.

Pharmacological Class

Selective 5-HT3 receptor antagonist.

How Supplied

Contact supplier.

Granisetron Hcl Tablets Indications

Indications

Prevention of nausea and vomiting associated with chemotherapy (including high-dose cisplatin), and with radiation (including total body irradiation and fractionated abdominal radiation).

Granisetron Hcl Tablets Dosage and Administration

Adult

Chemotherapy: give only on the days chemotherapy is given. 2mg up to 1 hour before chemotherapy; or, 1mg up to 1 hour before chemotherapy, then 1mg 12 hours after initial dose. Radiation: 2mg within 1 hour of radiation.

Children

Use IV form.

Granisetron Hcl Tablets Contraindications

Not Applicable

Granisetron Hcl Tablets Boxed Warnings

Not Applicable

Granisetron Hcl Tablets Warnings/Precautions

Warnings/Precautions

Abdominal surgery. May mask progressive ileus and/or gastric distention. Pre-existing arrhythmias or cardiac conduction disorders. Cardiac disease, concomitant cardio-toxic chemotherapy or electrolyte abnormalities: increased risk of QT prolongation. Pregnancy (Cat.B). Nursing mothers.

Granisetron Hcl Tablets Pharmacokinetics

See Literature

Granisetron Hcl Tablets Interactions

Interactions

Caution with drugs that affect CYP450 or prolong the QT interval.

Granisetron Hcl Tablets Adverse Reactions

Adverse Reactions

Headache, asthenia, diarrhea, constipation; QT prolongation.

Granisetron Hcl Tablets Clinical Trials

See Literature

Granisetron Hcl Tablets Note

Notes

Formerly known under the brand name Kytril.

Granisetron Hcl Tablets Patient Counseling

See Literature